Contineum Therapeutics, Inc. (CTNM)

Contineum Therapeutics Revenue

In the year 2023, Contineum Therapeutics had annual revenue of $50.00M.

• Revenue (ttm): $50.00M
• Revenue Growth: n/a
• P/S Ratio: n/a
• Revenue / Employee: $1,612,903
• Employees: 31
• Market Cap: 364.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	50.00M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.